Tivantinib
Tivantinib
c-Met 抑制剂;(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮
Tivantinib
c-Met 抑制剂;(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮
Tivantinib
-
产品编号: CTR447200
-
CAS号: 905854-02-6
-
分子式:C23H19N3O2
-
分子量:369.42
英文别名:
ARQ 197
参考文献:
Pento, J.T. et al.: Drugs Fut., 36, 893 (2011); Munshi, N. et al.: Mol. Cancer Ther., 9, 1544 (2010); Bagai, R. et al.: IDrugs, 13, 404 (2010);
Tivantinib is a hepatocyte growth factor receptor (proto-oncogene c-Met; MET) inhibitor. Tivantinib inhibits human c-Met receptor tyrosine kinase selectively and is a promising therapeutic option for the treatment of c-Met-associated cancers.
搜索质检报告(COA)
搜索MSDS